메뉴 건너뛰기




Volumn 5, Issue 3, 2004, Pages

Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): A technical note

Author keywords

Desolubilization; Micellization; pH; SLS; Solubilization; Surfactant

Indexed keywords

2 (2 THIOPHENYL) 4 AZABENZIMIDAZOLE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DODECYL SULFATE SODIUM; PG 300995; UNCLASSIFIED DRUG; DRUG DERIVATIVE; SODIUM LAURETH SULFATE;

EID: 23144449959     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt050345     Document Type: Article
Times cited : (58)

References (5)
  • 2
    • 0000610827 scopus 로고
    • Solubility and distribution phenomena
    • 4th ed. Philadelphia, PA: Lea & Febiger
    • Martin A, Bustamante P, Chun AHC. Solubility and distribution phenomena. In: Physical Pharmacy. 4th ed. Philadelphia, PA: Lea & Febiger; 1993:212-250.
    • (1993) Physical Pharmacy , pp. 212-250
    • Martin, A.1    Bustamante, P.2    Chun, A.H.C.3
  • 3
    • 0001938921 scopus 로고    scopus 로고
    • Solubilization by surfactants
    • New York, NY: Oxford University Press
    • Yalkowsky SH. Solubilization by surfactants. In: Solubility and Solubilization in Aqueous Media. New York, NY: Oxford University Press; 1999:236-315.
    • (1999) Solubility and Solubilization in Aqueous Media , pp. 236-315
    • Yalkowsky, S.H.1
  • 4
    • 0032896518 scopus 로고    scopus 로고
    • Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20
    • Li P, Tabibi SE, Yalkowsky SH. Solubilization of ionized and un-ionized flavopiridol by ethanol and polysorbate 20. J Pharm Sci. 1999;88:507-509.
    • (1999) J. Pharm. Sci. , vol.88 , pp. 507-509
    • Li, P.1    Tabibi, S.E.2    Yalkowsky, S.H.3
  • 5
    • 0025077497 scopus 로고
    • A stability indicating high-performance liquid chromatographic assay of erythromycin estolate in pharmaceutical dosage forms
    • Stubbs C, Kanfer I. A stability indicating high-performance liquid chromatographic assay of erythromycin estolate in pharmaceutical dosage forms. Int J Pharm. 1990;63:113-119.
    • (1990) Int. J. Pharm. , vol.63 , pp. 113-119
    • Stubbs, C.1    Kanfer, I.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.